307 related articles for article (PubMed ID: 21107737)
1. Analysis of thrombophilic genetic mutations in patients with Sheehan's syndrome: is thrombophilia responsible for the pathogenesis of Sheehan's syndrome?
Gokalp D; Tuzcu A; Bahceci M; Ayyildiz O; Yurt M; Celik Y; Alpagat G
Pituitary; 2011 Jun; 14(2):168-73. PubMed ID: 21107737
[TBL] [Abstract][Full Text] [Related]
2. The association of factor V G1961A (factor V Leiden), prothrombin G20210A, MTHFR C677T and PAI-1 4G/5G polymorphisms with recurrent pregnancy loss in Bosnian women.
Jusić A; Balić D; Avdić A; Pođanin M; Balić A
Med Glas (Zenica); 2018 Aug; 15(2):158-163. PubMed ID: 29703881
[TBL] [Abstract][Full Text] [Related]
3. [Prevalence of thrombophilic mutations of FV Leiden, prothrombin G20210A and PAl-1 4G/5G and their combinations in a group of 1450 healthy middle-aged individuals in the Prague and Central Bohemian regions (results of FRET real-time PCR assay)].
Kvasnicka J; Hájková J; Bobcíková P; Kvasnicka T; Dusková D; Poletínová S; Kieferová V
Cas Lek Cesk; 2012; 151(2):76-82. PubMed ID: 22515013
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors of Thrombophilia-Related Mutations for Early and Late Pregnancy Loss.
Borsi E; Potre O; Ionita I; Samfireag M; Secosan C; Potre C
Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674167
[No Abstract] [Full Text] [Related]
5. Plasminogen activator inhibitor-1, factor V, factor II and methylenetetrahydrofolate reductase polymorphisms in women with recurrent miscarriage.
Pietropolli A; Giuliani E; Bruno V; Patrizi L; Piccione E; Ticconi C
J Obstet Gynaecol; 2014 Apr; 34(3):229-34. PubMed ID: 24484533
[TBL] [Abstract][Full Text] [Related]
6. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
[TBL] [Abstract][Full Text] [Related]
7. Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.
Falvella FS; Cremolini C; Miceli R; Nichetti F; Cheli S; Antoniotti C; Infante G; Martinetti A; Marmorino F; Sottotetti E; Berenato R; Caporale M; Colombo A; de Braud F; Di Bartolomeo M; Clementi E; Loupakis F; Pietrantonio F
Pharmacogenomics J; 2017 Jul; 17(4):331-336. PubMed ID: 27001121
[TBL] [Abstract][Full Text] [Related]
8. Factor V Leiden, prothrombin G20210A, and methylene tetrahydrofolate reductase mutations and stillbirth: the Stillbirth Collaborative Research Network.
Silver RM; Saade GR; Thorsten V; Parker CB; Reddy UM; Drews-Botsch C; Conway D; Coustan D; Dudley DJ; Bukowski R; Rowland Hogue CJ; Pinar H; Varner MW; Goldenberg R; Willinger M
Am J Obstet Gynecol; 2016 Oct; 215(4):468.e1-468.e17. PubMed ID: 27131585
[TBL] [Abstract][Full Text] [Related]
9. MTHFR (C677T, A1298C), FV Leiden polymorphisms, and the prothrombin G20210A mutation in arterial ischemic stroke among young tunisian adults.
M'barek L; Sakka S; Meghdiche F; Turki D; Maalla K; Dammak M; Kallel C; Mhiri C
Metab Brain Dis; 2021 Mar; 36(3):421-428. PubMed ID: 33400068
[TBL] [Abstract][Full Text] [Related]
10. Thrombophilic mutations as risk factor for retinal vein occlusion: a case-control study.
Russo PD; Damante G; Pasca S; Turello M; Barillari G
Clin Appl Thromb Hemost; 2015 May; 21(4):373-7. PubMed ID: 24569626
[TBL] [Abstract][Full Text] [Related]
11. Interaction of thrombophilic SNPs in patients with unexplained infertility-multifactor dimensionality reduction (MDR) model analysis.
Milenkovic J; Milojkovic M; Mitic D; Stoimenov TJ; Smelcerovic Z; Stojanovic D; Vujic S; Bojanic N
J Assist Reprod Genet; 2020 Jun; 37(6):1449-1458. PubMed ID: 32399796
[TBL] [Abstract][Full Text] [Related]
12. Hyperbaric oxygen treatment results in a group of Turkish central retinal artery occlusion patients with a combined presence of thrombophilic mutations.
Çevik MÖ; Bagli BS; Çevik SG
Undersea Hyperb Med; 2020; 47(1):65-73. PubMed ID: 32176948
[TBL] [Abstract][Full Text] [Related]
13. Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.
Kuhli-Hattenbach C; Hellstern P; Nägler DK; Kohnen T; Hattenbach LO
Ophthalmic Genet; 2017; 38(5):413-417. PubMed ID: 28085526
[TBL] [Abstract][Full Text] [Related]
14. The role of classic risk factors and prothrombotic factor gene mutations in ischemic stroke risk development in young and middle-aged individuals.
Supanc V; Sonicki Z; Vukasovic I; Solter VV; Zavoreo I; Kes VB
J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):e171-6. PubMed ID: 24189452
[TBL] [Abstract][Full Text] [Related]
15. A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss.
Yenicesu GI; Cetin M; Ozdemir O; Cetin A; Ozen F; Yenicesu C; Yildiz C; Kocak N
Am J Reprod Immunol; 2010 Feb; 63(2):126-36. PubMed ID: 19906129
[TBL] [Abstract][Full Text] [Related]
16. The role of hypercoagulability in ischemic colitis.
Tsimperidis AG; Kapsoritakis AN; Linardou IA; Psychos AK; Papageorgiou AA; Vamvakopoulos NC; Kyriakou DS; Potamianos SP
Scand J Gastroenterol; 2015 Jul; 50(7):848-55. PubMed ID: 25656775
[TBL] [Abstract][Full Text] [Related]
17. The effects of genetic polymorphisms and diabetes mellitus on the development of peripheral artery disease.
Yalım Z; Tutgun Onrat S; Alan S; Aldemir M; Avşar A; Doğan İ; Onrat E
Turk Kardiyol Dern Ars; 2020 Jul; 48(5):484-493. PubMed ID: 32633259
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Factor V G1691A, prothrombin G20210A, Factor XIII V34L, MTHFR A1298C, MTHFR C677T and PAI-1 4G/5G genotype frequencies of patients subjected to cardiovascular disease (CVD) panel in south-east region of Turkey.
Oztuzcu S; Ergun S; Ulaşlı M; Nacarkahya G; Iğci YZ; Iğci M; Bayraktar R; Tamer A; Çakmak EA; Arslan A
Mol Biol Rep; 2014 Jun; 41(6):3671-6. PubMed ID: 24532105
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients.
Dölek B; Eraslan S; Eroğlu S; Kesim BE; Ulutin T; Yalçiner A; Laleli YR; Gözükirmizi N
Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Factor V Leiden, Prothrombin G20210A, MTHFR C677T and MTHFR A1298C gene polymorphisms in retinopathy of prematurity in a Turkish cohort.
Aydin H; Gunay M; Celik G; Gunay BO; Aydin UT; Karaman A
Ophthalmic Genet; 2016 Dec; 37(4):415-418. PubMed ID: 27018927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
